Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Traws Pharma, Inc.ONTX · Entity 8032 | Director | August 10, 2023 | August 14, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Traws Pharma, Inc.
Report date August 10, 2023 · Filed August 14, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.02 · Expires 2033-08-10 | Direct | 66,468 |
Reported balance
After 2023-08-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-08-10 · Grant · Acquired 66,468 · Balance 66,468 F1: These options vest 100% on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: These options vest 100% on the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2023 Filed Aug 14, 2023 21:49 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 66,468 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001415889-23-012231 · form4-08142023_090853.xml · derivative · entry 1 Atadja Peter · CIK 0001958563 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,468 Underlying: Common Stock · 66,468 shares Expires 2033-08-10 F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 23:56 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 100,000 | $0.00 Strike: $0.71 | $0.00 |
DisclosureSEC source: 0001415889-22-012767 · form4-12192022_111223.xml · derivative · entry 1 Atadja Peter · CIK 0001958563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-12-15 F1 · derivative.exercise_date: These options vest in 3 installments on the anniversary of the grant date: 33% on the first anniversary, 33% on the second anniversary and 34% on the third anniversary. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.